ARS Pharmaceuticals: Lawsuits And Cash Burn Are Priced In, Yet The Stock Keeps Falling
ARS Pharmaceuticals’ neffy adoption and insurance hurdles have driven cash burn and a falling share price, while management targets…
Cypriot Invests NASDAQ
ARS Pharmaceuticals, Inc.
SPRY
1 story
$364M Market cap · 2026-10-29
Get SPRY news in Claude, ChatGPT or your own code. See plans
Cypriot Invests 